Theresienkrankenhaus und St. Hedwigkliniken GmbH
Mannheim, 68165, Germany
NCT Number: NCT04340856
The aim of this retrospective cohort study is to analyze all available data of patients with chronic megacolon in three clinical centers with respect of conservative and surgical therapies.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Mannheim, 68165, Germany
Megacolon may be defined as dilatation of the abdominal colon with a minimum of 9 cm in diameter and the absence of mechanical obstruction. Chronic megacolon in adults is an acquired uncommon condition that generally is associated with constipation. It has to be distinguished from other forms of megacolon such as acute toxic megacolon, acute non-toxic megacolon (Ogilvie´s-syndrome) and congenital megacolon (Hirschsprung disease). Regardless of concomitant diseases and causes, most patients with chronic megacolon were treated by laxative measures. Less is known about the optimal conservative therapy . If conservative measures fail, there are several surgical options, depending upon anorectal function. However, less in known about the optimal surgical therapy of patients with chronic megacolon. The aim of this retrospective cohort study is to analyze all available data of patients with chronic megacolon in three clinical centers with respect of conservative and surgical therapies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There are no guidelines to direct surgical therapy in patients with chronic megacolon. Historically, it is the surgeons individual choice to use one of the above mentioned surgical treatments. Therefore, the aim of this study is to analyze the success and downsides of the different surgical approaches.
Other names: Subtotal colectomy with ileorectal anastomosis, Diverting loop ileostomy, Colectomy with ileoanal anastomosis, Decompressive cecostomy with periodic antegrade enemas, Segmental colon resection
There are no guidelines to direct laxative measures in patients with chronic megacolon. Historically, it is the gastroenterologists individual choice to use one of the above mentioned laxative measures. Therefore, the aim of this study is to analyze the success and downsides of the different Laxative measures.
Other names: High-colonic water enema, Water-soluble contrast enema, PEG electrolyte solution, Colon decompression probe, Prucaloprid, Bisacodyl
Time frame: One year after inpatient treatment (conservative/surgery)
Number of constipation crises leading to further hospital admissions: n
Time frame: Three months after inpatient treatment (conservative/surgery)
Hospital stay after inpatient treatment (conservative/surgery): days
Time frame: 30 days after inpatient treatment (conservative/surgery)
Any adverse event after inpatient treatment (conservative/surgery): n
Theresienkrankenhaus und St. Hedwig-Klinik GmbH
Other
Retrospective, Uncontrolled Multcentric Cohort Study on the Therapy of Chronic Megalon (CoMeC)
Acronym: CoMeC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07470892
Colonic Diseases, Constipation
View Trial DetailsNCT02442596
Colonic Diseases, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT07736131
Colon Cancer, Colonic Diseases
View Trial Details